News | January 28, 2014

Infraredx Plans Commercial Manufacturing of TVC Imaging System in Japan

Infraredx Inc. TVC Imaging System Intravascular Coronary Artery Disease
January 28, 2014 — Infraredx Inc.’s TVC Imaging System will be manufactured and distributed in Japan by Nipro Corp. Infraredx intends to commercialize the TVC Imaging System in Japan, China, Korea and other Asia Pacific markets.
The companies entered a five-year distribution agreement in 2012 and anticipate regulatory approval from Japan’s Pharmaceuticals and Medical Device Agency (PMDA) in 2014. Infraredx received a $25 million equity investment from Nipro in August 2013, and anticipates a minimum of $50 million in revenues during the duration of the agreement.
The TVC Imaging System console will be the first of nine products scheduled for commercial manufacturing at the new facility in Yamanashi Prefecture. Production is scheduled to begin in 2015. 
Intravascular ultrasound (IVUS), one of the imaging technologies used by the multimodal TVC Imaging System, is the standard of care in Japan and is used to guide more than 80 percent of percutaneous coronary intervention (PCI) procedures. The TVC Imaging System offers IVUS integrated with near-infrared spectroscopy (NIRS) for lipid core plaque detection. The TVC Imaging System can enable physicians to visualize the presence of plaques, quantify the degree of vessel stenosis (narrowing) and identify lipid core plaques suspected to be prone to rupturing and causing dangerous blockages.
The TVC Imaging System is an intravascular imaging system that intends to aid physicians evaluate true vessel characterization for treating coronary artery disease. The TVC Imaging System helps interventional cardiologists identify which patients are prone to complications during stenting and predict the risk of peri-procedural heart attacks by assessing not only the degree of stenosis, but also the presence and extent of lipid core plaques (LCP).
The device is approved in both the United State and Europe to detect LCPs. NIRS measurements have been made in over 5,000 patients in over 100 hospitals worldwide.
For more information, visit

Related Content

IVUS Demonstrates Greater Visualization of Dissections in iDissection Classification Study
News | Intra-Vascular Ultrasound (IVUS) | July 12, 2018
Intact Vascular Inc. announced the publication of the iDissection Classification trial results in the current issue of...
Infraredx Highlights Value of IVUS + NIRS for Detecting Lipid Core Plaque at ACC.18
News | Intra-Vascular Ultrasound (IVUS) | March 13, 2018
March 13, 2018 –  Infraredx, a company that works in...
Philips, Volcano, IVUS, vein obstruction diagnosis, multiplanar X-ray venography, VIDIO study
News | Intra-Vascular Ultrasound (IVUS) | February 29, 2016
Philips announced that new clinical trial data demonstrates the benefits of its intravascular ultrasound (IVUS)...
Overlay Init